Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neuroendocrine Tumors 7Neoplasms 6Colorectal Neoplasms 5Carcinoma, Hepatocellular 5Carcinoid Tumor 5Stomach Neoplasms 4Esophageal Neoplasms 4Acromegaly 4Weight Loss 3Rectal Neoplasms 3Pancreatic Neoplasms 3Diarrhea 3Carcinoma 3Breast Neoplasms 3Vipoma 2Thymoma 2Somatostatinoma 2Pituitary Neoplasms 2Ovarian Neoplasms 2Neoplasm Metastasis 2Malnutrition 2Intestinal Obstruction 2Insulinoma 2Glucagonoma 2Colonic Neoplasms 2Carcinoma, Islet Cell 2Adenoma, Islet Cell 2Zollinger-Ellison Syndrome 1Waldenstrom Macroglobulinemia 1Vulvar Neoplasms 1

Interventions

Gemcitabine 3Albumin-Bound Paclitaxel 3130-nm albumin-bound paclitaxel 3Ocoxin 2Metformin 2Clomiphene 2relacorilant 1pralsetinib 1pembrolizumab 1parathyroid hormone-related peptide (1-36) 1niraparib 1napabucasin 1Spironolactone 1Paclitaxel 1Octreotide 1Leuprolide 1Irinotecan 1Immune Checkpoint Inhibitors 1Filgrastim 1Eating 1Cisplatin 1Chorionic Gonadotropin 1Carboplatin 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Endocrine System Diseases × Octreotide × Clear all
NCT02385617 2023-11-27

Food Intake and Gut Hormones in Patients Who Have Undergone Upper Gastrointestinal Surgery for Cancer

St. James's Hospital, Ireland

Phase NA Completed
20 enrolled
Gastrointestinal

Endocrine System Diseases, Esophageal Neoplasms, Stomach Neoplasms, Weight Loss, Malnutrition

Data powered by HemOnc (CC BY 4.0) Colophon âš¡